Логин: Пароль: ?
 
Продукты питания Ткань, одежда, обувь, постельное белье, текстиль Строительные материалы Бумага, пластик, промтовары Биотопливо Продукция для сельского хозяйства, зоотовары Косметика, средства гигиены Медицинские товары и препараты, лекарства Иное

 

Наши партнеры:

 

Новости/Аналитика

Israel - a global leader in the study of the therapeutic properties of cannabis

12.04.2017

To date, Israel has a state program under the national health insurance scheme, in which nine licensed producers of psychoactive hemp provide cannabisa supplies of 30 grams per month for more than 26,000 registered patients. The market of therapeutic hemp of Israel for today is estimated at $ 15-20 million, and, despite the small size, the government of the country has attracted more than $ 100 million of international investments in this sector.
 
The modern history of the study of medical cannabis begins in Israel. This country with scanty fossils, having taken from the moment of its foundation the course on the development of its only truly valuable and huge resource - scientific potential, has become the world-wide recognized leader in the study of the pharmacological properties of cannabis.
 
In the 1960s, an organic chemist, Dr. Rafael Mesulam, began research. Previously, no one worked on the chemistry of cannabinoids and the constituents of cannabis were of little interest to anyone. The Government of Israel supported these studies, the Ministry of Health issued a permit and, together with the police, provided supplies of cannabis to the laboratory of Dr. Meshulam for study. And this happened precisely at a time when, in many other countries, hemp was classified as a "narcotic plant" and studies were banned. It was believed that this plant has no prospects for medical use. At the time of the beginning of the research in Israel, only in the US scientists could work in this field, but all the studies were under strict control of the federal government.
 
In 1964, the first two components of cannabis were discovered: tetrahydrocannabinol and cannabidiol. Since then, for 50 years, Dr. Meshulam has been conducting research, attracting specialists from all over the world. During these years, more than 20,000 experiments were carried out. It is noted that medical hemp has the potential to treat more than 105 diseases, which are very difficult to treat with currently known drugs (epilepsy, type II diabetes, multiple sclerosis, Parkinson's disease, Alzheimer's disease, migraine, post-traumatic stress disorder, some forms of cancer, and Etc.).
 
In the late 1970s, US pharmacologists, using Meshulam's development, created the drug "Marinol", used as an antiemetic for chemotherapy, recommended as an appetite stimulant in people with acquired immune deficiency syndrome (AIDS).
 
To date, Israel has a state program under the national health insurance scheme, in which nine licensed producers of psychoactive hemp provide cannabisa supplies of 30 grams per month for more than 26,000 registered patients. The market of therapeutic hemp of Israel for today is estimated at $ 15-20 million, and, despite the small size, the government of the country has attracted more than $ 100 million of international investments in this sector.
 
The government recently announced in the allocation of more than $ 2 million for the development, as well as the name of 13 strains of cannabis, treating certain types of diseases. The Ministry of Agriculture in the person of Uri Ariel has expanded the number of licenses for the cultivation of cannabis, and provides all-round support to local producers of therapeutic hemp, increasing exports abroad.
 
The pharmaceutical giant TEVA launched the Syqe cannabinoid inhaler. Two other Israeli companies have developed sublingual tablets based on medical cannabis, which are now being tested, and are planned to be used to improve cognitive function and treat Alzheimer's.
 
Scientific discoveries made by Israeli scientists allowed the world community and the scientific community of the whole world to pay attention to the value of cannabis as an effective medicinal product. This has led to the fact that over the past few decades, some economically developed countries have legalized the use of cannabis for medical purposes and the study of the properties of this plant continues to gain momentum in pharmaceuticals around the world.
 
Canna-Tech - an annual international conference in Tel Aviv, brings together leading experts from around the world to exchange experiences and latest advances in the study of medical hemp.
 
At present, the Promised Land remains the most advanced country in the world in the study and application of the therapeutic properties of cannabis in the treatment of such serious diseases as epilepsy, diabetes and certain types of oncology.
Author: 
Ekaterina Tsyplakova
Объявления
Все объявления »